Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors
J. Clin. Invest. 113:11 doi:10.1172/JCI20911
[Go to this article.]

Problems with a PDF?

PDF - Download (649.94 KB)